Annual Inventory
$141.86 M
+$14.26 M+11.17%
December 31, 2024
Summary
- As of February 24, 2025, HALO annual inventory is $141.86 million, with the most recent change of +$14.26 million (+11.17%) on December 31, 2024.
- During the last 3 years, HALO annual inventory has risen by +$87.95 million (+163.15%).
- HALO annual inventory is now at all-time high.
Performance
HALO Inventory Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Inventory
$141.86 M
+$10.45 M+7.95%
December 31, 2024
Summary
- As of February 24, 2025, HALO quarterly inventory is $141.86 million, with the most recent change of +$10.45 million (+7.95%) on December 31, 2024.
- Over the past year, HALO quarterly inventory has stayed the same.
- HALO quarterly inventory is now -15.83% below its all-time high of $168.54 million, reached on March 31, 2024.
Performance
HALO Quarterly Inventory Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Inventory Formula
Inventory = Beginning Inventory + Purchases − Cost of Goods Sold
HALO Inventory Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +11.2% | 0.0% |
3 y3 years | +163.2% | +10.0% |
5 y5 years | +383.2% | +10.0% |
HALO Inventory Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +163.2% | -15.8% | +197.0% |
5 y | 5-year | at high | +383.2% | -15.8% | +383.2% |
alltime | all time | at high | >+9999.0% | -15.8% | >+9999.0% |
Halozyme Therapeutics Inventory History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | $141.86 M(+11.2%) | $141.86 M(+8.0%) |
Sep 2024 | - | $131.41 M(-17.5%) |
Jun 2024 | - | $159.31 M(-5.5%) |
Mar 2024 | - | $168.54 M(+32.1%) |
Dec 2023 | $127.60 M(+27.4%) | $127.60 M(-1.0%) |
Sep 2023 | - | $128.92 M(-2.6%) |
Jun 2023 | - | $132.41 M(+23.1%) |
Mar 2023 | - | $107.52 M(+7.4%) |
Dec 2022 | $100.12 M(+85.7%) | $100.12 M(-3.1%) |
Sep 2022 | - | $103.28 M(+5.8%) |
Jun 2022 | - | $97.61 M(+104.4%) |
Mar 2022 | - | $47.76 M(-11.4%) |
Dec 2021 | $53.91 M(-11.3%) | $53.91 M(-3.7%) |
Sep 2021 | - | $55.98 M(-4.4%) |
Jun 2021 | - | $58.55 M(+0.4%) |
Mar 2021 | - | $58.34 M(-4.0%) |
Dec 2020 | $60.75 M(+106.9%) | $60.75 M(+5.3%) |
Sep 2020 | - | $57.70 M(+19.5%) |
Jun 2020 | - | $48.27 M(+16.5%) |
Mar 2020 | - | $41.45 M(+41.2%) |
Dec 2019 | $29.36 M(+29.8%) | $29.36 M(-18.6%) |
Sep 2019 | - | $36.05 M(-17.9%) |
Jun 2019 | - | $43.90 M(+40.5%) |
Mar 2019 | - | $31.24 M(+38.1%) |
Dec 2018 | $22.63 M(+339.7%) | $22.63 M(+23.7%) |
Sep 2018 | - | $18.29 M(+117.6%) |
Jun 2018 | - | $8.40 M(+91.3%) |
Mar 2018 | - | $4.39 M(-14.6%) |
Dec 2017 | $5.15 M(-64.8%) | $5.15 M(-44.9%) |
Sep 2017 | - | $9.33 M(-38.5%) |
Jun 2017 | - | $15.17 M(+6.2%) |
Mar 2017 | - | $14.29 M(-2.3%) |
Dec 2016 | $14.62 M(+54.1%) | $14.62 M(+13.8%) |
Sep 2016 | - | $12.85 M(+19.5%) |
Jun 2016 | - | $10.76 M(+4.0%) |
Mar 2016 | - | $10.35 M(+9.0%) |
Dec 2015 | $9.49 M(+48.1%) | $9.49 M(-14.5%) |
Sep 2015 | - | $11.10 M(+43.7%) |
Jun 2015 | - | $7.72 M(+3.2%) |
Mar 2015 | - | $7.48 M(+16.8%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2014 | $6.41 M(+3.8%) | $6.41 M(-7.4%) |
Sep 2014 | - | $6.92 M(-2.8%) |
Jun 2014 | - | $7.11 M(+5.2%) |
Mar 2014 | - | $6.76 M(+9.6%) |
Dec 2013 | $6.17 M(+131.0%) | $6.17 M(+60.4%) |
Sep 2013 | - | $3.85 M(+55.9%) |
Jun 2013 | - | $2.47 M(-9.9%) |
Mar 2013 | - | $2.74 M(+2.5%) |
Dec 2012 | $2.67 M(+370.8%) | $2.67 M(+22.2%) |
Sep 2012 | - | $2.19 M(+22.5%) |
Jun 2012 | - | $1.78 M(+19.2%) |
Mar 2012 | - | $1.50 M(+163.8%) |
Dec 2011 | $567.30 K(+193.3%) | $567.30 K(+448.6%) |
Sep 2011 | - | $103.40 K(+23.4%) |
Jun 2011 | - | $83.80 K(-66.3%) |
Mar 2011 | - | $248.50 K(+28.5%) |
Dec 2010 | $193.40 K(-83.3%) | $193.40 K(-82.0%) |
Sep 2010 | - | $1.08 M(-0.5%) |
Jun 2010 | - | $1.08 M(-6.7%) |
Mar 2010 | - | $1.16 M(0.0%) |
Dec 2009 | $1.16 M(+162.8%) | $1.16 M(-6.4%) |
Sep 2009 | - | $1.24 M(+54.1%) |
Jun 2009 | - | $803.50 K(+41.8%) |
Mar 2009 | - | $566.80 K(+28.4%) |
Dec 2008 | $441.30 K(-37.3%) | $441.30 K(-16.0%) |
Sep 2008 | - | $525.40 K(-19.1%) |
Jun 2008 | - | $649.30 K(-4.4%) |
Mar 2008 | - | $679.10 K(-3.5%) |
Dec 2007 | $703.50 K(+59.0%) | $703.50 K(-1.4%) |
Sep 2007 | - | $713.30 K(+15.0%) |
Jun 2007 | - | $620.30 K(+30.5%) |
Mar 2007 | - | $475.20 K(+7.4%) |
Dec 2006 | $442.50 K(+58.6%) | $442.50 K(+89.3%) |
Sep 2006 | - | $233.80 K(-43.5%) |
Jun 2006 | - | $414.10 K(+44.7%) |
Mar 2006 | - | $286.20 K(+2.6%) |
Dec 2005 | $279.00 K(+438.6%) | $279.00 K(+514.5%) |
Sep 2005 | - | $45.40 K(+46.0%) |
Jun 2005 | - | $31.10 K(-34.0%) |
Mar 2005 | - | $47.10 K(-9.1%) |
Dec 2004 | $51.80 K | $51.80 K |
FAQ
- What is Halozyme Therapeutics annual inventory?
- What is the all time high annual inventory for Halozyme Therapeutics?
- What is Halozyme Therapeutics annual inventory year-on-year change?
- What is Halozyme Therapeutics quarterly inventory?
- What is the all time high quarterly inventory for Halozyme Therapeutics?
- What is Halozyme Therapeutics quarterly inventory year-on-year change?
What is Halozyme Therapeutics annual inventory?
The current annual inventory of HALO is $141.86 M
What is the all time high annual inventory for Halozyme Therapeutics?
Halozyme Therapeutics all-time high annual inventory is $141.86 M
What is Halozyme Therapeutics annual inventory year-on-year change?
Over the past year, HALO annual inventory has changed by +$14.26 M (+11.17%)
What is Halozyme Therapeutics quarterly inventory?
The current quarterly inventory of HALO is $141.86 M
What is the all time high quarterly inventory for Halozyme Therapeutics?
Halozyme Therapeutics all-time high quarterly inventory is $168.54 M
What is Halozyme Therapeutics quarterly inventory year-on-year change?
Over the past year, HALO quarterly inventory has changed by $0.00 (0.00%)